Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
批准号:
10611456
负责人:
Wenshe Ray Liu
金额:
$18.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2025-02-28
关键词:
2019-nCoVAcuteAdoptedAldehydesAnimal ModelAnimalsApoptosisBackCOVID-19COVID-19 pandemicCOVID-19 preventionCOVID-19 therapeuticsCOVID-19 vaccineCaco-2 CellsCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeChemicalsCommunicable DiseasesCoronavirusCountryDataDetectionDevelopmentDiseaseDrug or chemical Tissue DistributionEnzymesFDA Emergency Use AuthorizationGenomeGoalsHealth PromotionHumanHydrolysisImageIn VitroInvestigationMeasuresMissionMusMutateNonstructural ProteinOpen Reading FramesOrganOrganismParalysedPathogenesisPatternPeptide HydrolasesPeptidesPermeabilityPharmaceutical PreparationsProductionProtocols documentationPublic HealthRNARNA VirusesReagentRegulationReportingReproductionResearchResearch PersonnelResistanceSARS-CoV-2 infectionShipsStructureTestingTherapeuticTissue imagingTissuesTransgenic OrganismsTranslatingUnited States National Institutes of HealthViralViral PathogenesisVirusVirus DiseasesVirus ReplicationWorld Health Organizationanalogcellular imagingfluorophoreimprovedin vivo imaginginhibitormonolayernon-invasive imagingpandemic diseasepathogenpathogenic viruspolypeptideresorufinstable cell lineunnatural amino acids
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
COVID-19 is the currently prevailing pandemic that has paralyzed much of the world. The viral pathogen of
COVID-19 is SARS-CoV-2, a coronavirus with a positive sense RNA genome. Its production in the human cell
host requires the activity of its main protease (MPro). As a unique enzyme that is essential to SARS-CoV-2, MPro
is acutely toxic to the host cell indicating that it is tightly regulated during viral infection and replication. Its activity
also represents active viral reproduction in organs and tissues in an infected host organism. Therefore, the
detection of MPro activity in SARS-CoV-2-infected cells and animals will provide essential information about MPro
activity regulation in the host cell and SARS-CoV-2 spreading and distribution in a host organism respectively
for the elucidation of SARS-CoV-2 replication and pathogenesis. Noninvasive imaging reagents will be critical
for the detection of MPro activity in order to avoid interference with both the virus and the host. With an ultimate
goal of understanding the SARS-CoV-2 replication in infected cells and elucidating SARS-CoV-2 spreading
patterns and organ/tissue distribution in infected animals, the current proposal aims to develop noninvasive
fluorogenic and chemiluminogenic MPro substrates that have highly cellular stability and tissue penetrability for
imaging MPro activity. Three specific aims will be pursued by 1) developing fluorogenic and chemiluminogenic
MPro substrates; 2) characterizing fluorogenic and chemiluminogenic MPro substrates on their selectivity, cellular
stability and tissue penetrability; and 3) conducting cellular and in vivo imaging of SARS-CoV-2 infection. The
successful completion of the proposed study will 1) result in fluorogenic and chemiluminogenic MPro substrates
with optimal cellular stability and tissue penetratability that can be broadly adopted by COVID-19 researchers for
the investigation of SARS-CoV-2 replication and pathogenesis and 2) provide critical information for the
elucidation of Mpro activity regulation in SARS-CoV-2-infected cells and SARS-CoV-2 spreading patterns and
distribution in transgenic hACE2+ mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
-
批准号:10432895
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2022
-
负责人:Wenshe Ray Liu
-
依托单位:
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins
-
批准号:10406602
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2022
-
负责人:Wenshe Ray Liu
-
依托单位:
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins
-
批准号:10591531
-
项目类别:
-
资助金额:$51.94万
-
财政年份:2022
-
负责人:Wenshe Ray Liu
-
依托单位:
Targeting the ENL YEATS domain for the development of anti-leukemia agents
-
批准号:10357052
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2021
-
负责人:Wenshe Ray Liu
-
依托单位:
Targeting the ENL YEATS domain for the development of anti-leukemia agents
-
批准号:10534219
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2021
-
负责人:Wenshe Ray Liu
-
依托单位:
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications
-
批准号:10307614
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2019
-
负责人:Wenshe Ray Liu
-
依托单位:
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications
-
批准号:10063529
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2019
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8730263
-
项目类别:
-
资助金额:$4.17万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8821041
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8450284
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8161460
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8289395
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids
-
批准号:8658699
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2011
-
负责人:Wenshe Ray Liu
-
依托单位:
海外基金